ZyVersa Therapeutics Inc
ZVSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.66M
Close$
$0.02
90.2% downside
Current Fair Value
90.2% downsideOvervalued by 90.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.66 Million |
|---|---|
| Enterprise Value | $899.00 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.18 |
| Beta | 0.79 |
| Outstanding Shares | 8,095,921,000 |
Return
| Return on Equity | 173.38% |
|---|---|
| Return on Assets | -3299.39% |
| Return on Invested Capital | 174.54% |
Valuation & Multiples
| P/E Ratio | -0.91 |
|---|---|
| PEG | 4.45 |
| Price to Sales | - |
| Price to Book Ratio | -0.09 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.04 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.33 |
| Debt to Equity | -0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $1▼ 100.00% |
| Investors Holding | 1▼ 5.00% |
ESG Score
No data
About ZyVersa Therapeutics Inc
2,021 employees